Lekhaniya Mahakashaya in the Management of Lifestyle Disorders: A Critical Review

Review Article

Authors

  • Preeti Sharma Desh Bhagat University Author
  • Vinayak Raghunath Nande Desh Bhagat University Author

DOI:

https://doi.org/10.64280/JAA.2026.V2I1017

Keywords:

Lekhaniya Mahakashaya, Lekhana Karma, Obesity, Dyslipidemia, Metabolic Syndrome, Medoroga, Lifestyle Disorders

Abstract

Background: Lifestyle disorders including obesity, dyslipidemia, and metabolic syndrome represent a growing global health challenge. Lekhaniya Mahakashaya, a classical Ayurvedic formulation comprising ten medicinal herbs, has been traditionally employed for managing disorders of fat metabolism (Medodushti) through its unique Lekhana Karma (scraping action).

Objective: This critical review examines the concept of Lekhana Karma, evaluates the pharmacological profiles of the ten constituent drugs (Musta, Kushtha, Haridra, Daruharidra, Vacha, Ativisha, Katurohini, Chitraka, Chirabilva, and Haimavati), and synthesizes clinical evidence for their efficacy in obesity, dyslipidemia, and metabolic syndrome.

Methods: A comprehensive review of classical Ayurvedic texts, contemporary clinical trials, and pharmacological studies was conducted to evaluate the therapeutic potential of Lekhaniya Mahakashaya in lifestyle disorders.

Results: The constituent drugs predominantly possess Tikta (bitter), Katu (pungent), and Kashaya (astringent) Rasa; Laghu (light), Ruksha (dry), and Tikshna (sharp) Guna; Ushna Virya (hot potency); and Katu Vipaka (pungent post-digestive effect). Clinical studies demonstrate significant improvements in body mass index, lipid profiles, oxidative stress markers, and metabolic parameters. The formulation exhibits Medohara (lipolytic), Deepana (appetizer), Pachana (digestive), and Srotoshodhana (channel-cleansing) properties.

Conclusion: Lekhaniya Mahakashaya represents a promising therapeutic approach for lifestyle disorders through its multi-targeted pharmacological actions. However, larger randomized controlled trials with standardized formulations are needed to establish definitive clinical efficacy and safety profiles.

Author Biographies

  • Preeti Sharma, Desh Bhagat University

    Research Scholar

    Department of Dravyaguna Vigyan

  • Vinayak Raghunath Nande , Desh Bhagat University

    Professor

Downloads

Published

2026-04-05

Issue

Section

Articles